Witnesses

Greaney, Thomas College of the Law UC Hastings San Francisco, CA

06/12/19 Your Doctor/Pharmacist/Insurer Will See You Now: Competitive Implications of Vertical Consolidation in the Healthcare Industry

Scott Morton, Ph.D., Fiona M. Theodore Nierenberg Professor of Economics Yale School of Management New Haven, CT

06/12/19 Your Doctor/Pharmacist/Insurer Will See You Now: Competitive Implications of Vertical Consolidation in the Healthcare Industry

05/21/19 Understanding the Digital Advertising Ecosystem and the Impact of Data Privacy and Competition Policy

Capps, Cory Partner Bates White Economic Consulting Washington, DC

06/12/19 Your Doctor/Pharmacist/Insurer Will See You Now: Competitive Implications of Vertical Consolidation in the Healthcare Industry

Vandenberg, John D. Partner Klarquist Sparkman, LLP Sherwood, OR

06/11/19 The State of Patent Eligibility in America: Part III

O'Neill, Peter Executive Director Cleveland Clinic Innovations Cleveland, OH

06/11/19 The State of Patent Eligibility in America: Part III

Chotkowski, Kim Vice President, Head of Licensing Strategy and Operations InterDigital Washington, DC

06/11/19 The State of Patent Eligibility in America: Part III

Self, Laurie Senior Vice-President and Counsel, Government Affairs Qualcomm Washington, DC

06/11/19 The State of Patent Eligibility in America: Part III

Schecter, Manny Chief Patent Counsel IBM Armonk, NY

06/11/19 The State of Patent Eligibility in America: Part III

Deberadine, Robert Chief Intellectual Property Counsel Johnson & Johnson New Brunswick, NJ

06/11/19 The State of Patent Eligibility in America: Part III

Spetzler, David President and Chief Scientific Officer Caris Life Sciences Irving, TX

06/11/19 The State of Patent Eligibility in America: Part III

Holz, Byron Senior Intellectual Property Rights Licensing Counsel Nokia Snellville, GA

06/11/19 The State of Patent Eligibility in America: Part III

George, Sean Chief Executive Officer Invitae San Francisco, CA

06/11/19 The State of Patent Eligibility in America: Part III

Salsberg, Corey Vice President, Global Head IP Affairs Novartis Washington, DC

06/11/19 The State of Patent Eligibility in America: Part III

Blankstein, Michael Senior Vice President and Deputy General Counsel - Patents and Licensing Scientific Games Las Vegas, NV

06/11/19 The State of Patent Eligibility in America: Part III

Reilly, Sean Senior Vice President and Associate General Counsel The Clearing House Payments Company New York, NY

06/11/19 The State of Patent Eligibility in America: Part III

Hill, Laurie Vice President, Intellectual Property Genentech San Francisco, CA

06/11/19 The State of Patent Eligibility in America: Part III

Merino, Gonzalo Vice President and Chief Intellectual Property Counsel Regeneron Pharmaceuticals New York, NY

06/11/19 The State of Patent Eligibility in America: Part III

Dupont, Nicolas CEO and Executive Chairman Cyborg Inc. New York, NY

06/11/19 The State of Patent Eligibility in America: Part III

McAleenan, Kevin K. Acting Secretary United States Department of Homeland Security Washington, DC

06/11/19 The Secure and Protect Act: a Legislative Fix to the Crisis at the Southwest Border

03/06/19 Oversight of Customs and Border Protection’s Response to the Smuggling of Persons at the Southern Border

12/11/18 Oversight of U.S. Customs and Border Protection

Francer, Jeff General Counsel Association for Accessible Medicines Washington, DC

06/05/19 The State of Patent Eligibility in America: Part II

Patridge, Scott Immediate Past Chair, Intellectual Property Law Section American Bar Association Houston, TX

06/05/19 The State of Patent Eligibility in America: Part II

Brandon, Rick Associate General Counsel, The University of Michigan On behalf of Association of American Universities and the Association of University Technology Managers Ann Arbor, MI

06/05/19 The State of Patent Eligibility in America: Part II

Jenks, PhD, JD, William G. Principal, Jenks IP Law On behalf of Internet Association Washington, DC

06/05/19 The State of Patent Eligibility in America: Part II

Sauer, Hans Deputy General Counsel for Intellectual Property Biotechnology Innovation Organization Washington, DC

06/05/19 The State of Patent Eligibility in America: Part II

Morinville, Paul President U.S. Inventor Highland, IN

06/05/19 The State of Patent Eligibility in America: Part II

Showing page of 199